ATE199646T1 - Halbfeste arzneimittel sowie verfahren zu deren herstellung - Google Patents

Halbfeste arzneimittel sowie verfahren zu deren herstellung

Info

Publication number
ATE199646T1
ATE199646T1 AT94304657T AT94304657T ATE199646T1 AT E199646 T1 ATE199646 T1 AT E199646T1 AT 94304657 T AT94304657 T AT 94304657T AT 94304657 T AT94304657 T AT 94304657T AT E199646 T1 ATE199646 T1 AT E199646T1
Authority
AT
Austria
Prior art keywords
semi
production
medicinal products
bioactive substance
solid medicinal
Prior art date
Application number
AT94304657T
Other languages
English (en)
Inventor
Masao Ikeda
Tomoki Tatefuji
Hiroshi Yamauchi
Original Assignee
Hayashibara Biochem Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Biochem Lab filed Critical Hayashibara Biochem Lab
Application granted granted Critical
Publication of ATE199646T1 publication Critical patent/ATE199646T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
AT94304657T 1993-06-28 1994-06-27 Halbfeste arzneimittel sowie verfahren zu deren herstellung ATE199646T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5178614A JPH0776527A (ja) 1993-06-28 1993-06-28 半固形製剤とその製造方法

Publications (1)

Publication Number Publication Date
ATE199646T1 true ATE199646T1 (de) 2001-03-15

Family

ID=16051528

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94304657T ATE199646T1 (de) 1993-06-28 1994-06-27 Halbfeste arzneimittel sowie verfahren zu deren herstellung

Country Status (13)

Country Link
US (1) US5489577A (de)
EP (1) EP0630651B1 (de)
JP (1) JPH0776527A (de)
KR (1) KR100314820B1 (de)
AT (1) ATE199646T1 (de)
AU (1) AU685111B2 (de)
CA (1) CA2126932A1 (de)
DE (1) DE69426844T2 (de)
DK (1) DK0630651T3 (de)
FI (1) FI943103A7 (de)
NZ (1) NZ260867A (de)
PT (1) PT630651E (de)
TW (1) TW496744B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU695520B2 (en) * 1994-12-29 1998-08-13 Mochida Pharmaceutical Co., Ltd. Urinastatin-containing suppository
JP2001064181A (ja) * 1999-08-27 2001-03-13 Otsuka Pharmaceut Co Ltd 免疫賦活組成物
JP4866518B2 (ja) * 2001-09-21 2012-02-01 天藤製薬株式会社 坐剤の製造法
JP4866519B2 (ja) * 2001-09-21 2012-02-01 天藤製薬株式会社 坐剤の製造法
NZ523100A (en) * 2002-12-10 2005-02-25 Fonterra Co Operative Group A process for producing a carbohydrate composition
US7611709B2 (en) 2004-05-10 2009-11-03 Boehringer Ingelheim Pharma Gmbh And Co. Kg 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
DE102004022927A1 (de) * 2004-05-10 2005-12-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg 1,4 O-verknüpfte Saccharose-Derivate zur Stabilisierung von Antikörpern oder Antikörper-Derivaten
US7727962B2 (en) 2004-05-10 2010-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder comprising new compositions of oligosaccharides and methods for their preparation
US7723306B2 (en) 2004-05-10 2010-05-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
DE102004022928A1 (de) * 2004-05-10 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulver enthaltend neuartige Oligosacharidgemische und Verfahren zu deren Herstellung
DE102004022926A1 (de) * 2004-05-10 2005-12-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Sprühgetrocknete Pulver enthaltend zumindest ein 1,4 O-verknüpftes Saccharose-Derivat und Verfahren zu deren Herstellung
DE102006053375A1 (de) * 2006-11-10 2008-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mischung von Pulvern

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
EP0080879B1 (de) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Stabilisiertes Interferon enthaltende pharmazeutische Zusammensetzung
HU189251B (en) * 1982-04-07 1986-06-30 Asahi Kasei Kogyo Kk,Jp Process for stabilizing tumor necrosis factor
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
US4650665A (en) * 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4593038A (en) * 1985-04-03 1986-06-03 Burzynski Stanislaw R Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US4870059A (en) * 1985-11-27 1989-09-26 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Dehydration of hydrous matter with anhydrous maltose
US4851220A (en) * 1986-11-26 1989-07-25 Schering Corporation Stable oleaginous gel
DE3854275T2 (de) * 1987-03-06 1996-04-11 Kao Corp Äusserliches Hautpflegepräparat.
HU203204B (en) * 1987-09-15 1991-06-28 Sandoz Ag Process for producing suppository containing calcitonin and taurocholic acid
DE3731255A1 (de) * 1987-09-17 1989-04-06 Boehringer Ingelheim Int Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
US5266310A (en) * 1987-09-17 1993-11-30 Boehringer Ingelheim International Gmbh Stabilization of therapeutically active proteins in pharmaceutical preparations
US5215743A (en) * 1988-04-13 1993-06-01 Maninder Singh Tumor necrosis factor formulations
US5011824A (en) * 1988-11-16 1991-04-30 Kyowa Hakko Kogyo Co., Ltd. Rectal motilin preparation
ATE107517T1 (de) * 1989-05-25 1994-07-15 Takeda Chemical Industries Ltd Transdermales therapeutisches mittel.
JP2945993B2 (ja) * 1989-12-05 1999-09-06 武田薬品工業株式会社 外用剤
WO1991013601A1 (en) * 1990-03-15 1991-09-19 Rhône-Poulenc Rorer International (Holdings) Inc. Calcitonin suppository formulations
US5194261A (en) * 1990-11-27 1993-03-16 Virgil Pichierri Diaper rash treatment
EP0533938A4 (en) * 1991-02-19 1993-06-16 Tsumura & Co. Composition for rectal administration of difficultly absorbable peptide
IT1244500B (it) * 1991-03-21 1994-07-15 Pulitzer Italiana Impiego di sali minerali di trometamina in composizioni farmaceutiche a base di calcitonina somministrabili per via rettale in terapia umana
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels

Also Published As

Publication number Publication date
FI943103A0 (fi) 1994-06-28
TW496744B (en) 2002-08-01
KR100314820B1 (ko) 2002-06-20
FI943103L (fi) 1994-12-29
KR950000168A (ko) 1995-01-03
EP0630651A3 (de) 1996-11-06
EP0630651A2 (de) 1994-12-28
DE69426844D1 (de) 2001-04-19
US5489577A (en) 1996-02-06
EP0630651B1 (de) 2001-03-14
NZ260867A (en) 1996-01-26
AU6601994A (en) 1995-01-05
JPH0776527A (ja) 1995-03-20
DK0630651T3 (da) 2001-04-17
FI943103A7 (fi) 1994-12-29
PT630651E (pt) 2001-06-29
DE69426844T2 (de) 2001-08-23
AU685111B2 (en) 1998-01-15
CA2126932A1 (en) 1994-12-29

Similar Documents

Publication Publication Date Title
GB2139892B (en) Solid pharmaceutical preparation containing nifedipine
EP0221041A3 (de) Benzimidazolderivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
NL990012I2 (nl) Geneesmiddelen die salmeterol en fluticason bevatten.
UA41502C2 (uk) Стабілізований фармацевтичний препарат, який містить гормон росту і гістидин, кристали гормону росту, що містять гістидин, та спосіб їх одержання
CA2058835A1 (en) Stable pharmaceutical composition and method for its production
ATE199646T1 (de) Halbfeste arzneimittel sowie verfahren zu deren herstellung
EP1161956A4 (de) Medikamentenzusammensetzung
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
YU59192A (sh) Formulacija aerosola koje ne sadrže hlorofluorougljenična jedinjenja
ATE134133T1 (de) Präparat zur wirkstoffapplikation in kleinsttröpfchenform
ATE231882T1 (de) 7alpha-(epsilon-aminoalkyl)-estratriene, verfahren zu deren herstellung, pharmazeutische präparate, die diese 7alpha-(epsilon-aminoalkyl)- estratriene enthalten sowie deren verwendung zur herstellung von arzneimitteln
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
DE3776946D1 (de) Nasale verabreichung von arzneimitteln.
ATE175353T1 (de) Verfahren und system zur empfängnisverhütung
DE69025920D1 (de) Glykosaminoglykan-modifiertes Protein, Verfahren zu dessen Herstellung und pharmazeutische Zubereitungen, die es enthalten
DE3783356D1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
AU1935788A (en) A process for producing an administration and/or dosage form for medically active ingredients of drugs
IT1241997B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
DE3877151D1 (de) Melphalan oder melphalanhydrochlorid enthaltende pharmazeutische formulierungen sowie melphalan und melphalanhydrochlorid und verfahren zu ihrer herstellung.
DE3787477D1 (de) Nasal applizierbares Arzneimittel, Verfahren zu seiner Herstellung und seine Verwendung.
ATE110723T1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
ATE100095T1 (de) 2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
EP0271151A3 (de) Azumolen-Dosisformen
DE69531166D1 (de) Arzneistoff zur erleichterung der durch immunsuppressiva verursachten nebenwirkungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee